Market revenue in 2023 | USD 670.0 million |
Market revenue in 2030 | USD 1,166.8 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Functional genomics |
Fastest growing segment | Pathway Analysis |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery |
Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.
Functional genomics was the largest segment with a revenue share of 32.34% in 2023. Horizon Databook has segmented the Middle East & Africa genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2018 to 2030.
Various initiatives being undertaken by the government to raise awareness about various diseases, especially infectious diseases, are expected to boost market growth. Increasing spending by the government to raise awareness about lifestyle diseases is expected to create growth opportunities for key players in the market.
Lack of government investment may restrict the adoption of genome sequencing technologies. Several companies function within cost containment programs mandated by governments, which comprise international therapeutic reference pricing, compulsory generic substitution, rebates & discounts, price controls, and restrictions on physicians' prescriptions.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa genomics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account